Hamamatsu Photonics K.K. 6965
TSE · Japan · Electronic Technology
¥2,398.50-5.50 (-0.23%)
Market open· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Hamamatsu Photonics has developed the iPHEMOS®-DDX, an inverted emission microscope designed for failure analysis of advanced semiconductor packages, including AI chiplets, High Bandwidth Memory (HBM), 2.5D/3D packages, and large-scale semiconductor packages.
Hamamatsu Photonics K.K has delivered a 52.7% return over the past year, which naturally puts the spotlight on whether that share price now lines up with the cash the business is expected to generate. For anyone watching Hamamatsu Photonics K.K after such a strong 12 month run, the key issue is how that market enthusiasm stacks up against the company’s underlying cash flows. The 52.7% gain over the last year puts recent buyers in a strong position. It also raises the question of whether the...
Accelerating momentum across major industry heavyweights—highlighted by Thermo Fisher Scientific’s Q2 2026 revenue beat, Hamamatsu Photonics’ launch of its dedicated Lasers & Fibers Business Unit, and BD’s $4.98 billion Q3 performance—is driving rapid adoption of optical diagnostic and imaging solutions worldwide. This report provides an in-depth analysis of key technological advancements, regional market shares, and competitive strategies across the global biophotonics sector. Biophotonics Mark
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.